Grant Life Sciences Enters Into Memorandum Of Understanding (MOU) With Chinese Medical Device Company To Manufacture And Distribute Grant's Point-Of-Care, Rapid Diagnostic Tests In China And Hong Kong

Grant Life Sciences Inc. (OTC BB: GLIF) announced today that it has signed a Memorandum of Understanding (MOU) with GuongDong Kangermei Industry Development Co. Ltd. (GDK) to license the manufacturing and distribution rights of Grant's AccuDx line of rapid, point-of-care (POC) tests in China and Hong Kong. Below is a summary of the key terms of the MOU, which will be used as the basis for a definitive License and Collaboration Agreement between Grant and GDK: